Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
PSP-PARIS Study Group
Graduate School of Biomedical Sciences
Icahn School of Medicine at Mount Sinai
Microbiology
Friedman Brain Institute
Genetics and Genomic Sciences
Icahn Genomics Institute
Medicine
Medicine - Infectious Diseases
Mount Sinai Global Health and Emerging Pathogens Institute
Research output
:
Contribution to journal
›
Article
›
peer-review
344
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
COVID-19
100%
Convalescent
100%
Spike Protein
50%
South Africa
33%
Neutralizing Activity
33%
Virus
16%
Metropolitan Areas
16%
Immune Escape
16%
Vaccination
16%
Receptor Binding
16%
Wild Type Virus
16%
Protein Binding
16%
Binding Activity
16%
N-terminal Domain
16%
Botswana
16%
Travellers
16%
Unvaccinated
16%
Omicron BA.1
16%
Spike Gene
16%
Neutralizing Proteins
16%
Omicron Spike
16%
Superspreader
16%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Omicron Coronavirus Variant
100%
Spike
71%
Wild Type
42%
Receptor Binding
14%
Immune Escape
14%
Amino Terminal Sequence
14%
Binding Affinity
14%
Protein Binding
14%
Virus Type
14%